An open access journal, published by Sunandan Divatia School of Science, NMIMS
INDEX WITH: EBSCOhost, Index Copernicus, Google Scholar, HINARI, CiteFactor, DRJI, Advanced Sciences Index
Editorial: Contemporary Cancer Therapy
Author(s): Dhananjaya Saranath and Aparna Khanna
Biomed Res J 2017;4(1):1-7
Sunandan Divatia School of Science, NMIMS (Deemed-to-be University), Vile Parle (W), Mumbai - 400056, India.
Abstract: On the Public Health scenario globally the major issues in provision of effective care from 'Precision Medicine to Precision Care' that need urgent solutions include 'Antimicrobial resistance to negate the estimated death of 10 million individuals annually due to Antimicrobial Resistance by 2050', and 'Understanding of Cancer Biology with consequent complete cure in Cancer' and translation care with patient centred approach. Besides an impetus for prioritising 'Preventive Medicine' in both communicable and non-communicable diseases is needed. The laudable 'Sustainable Development Goal target' of reducing maternal mortality to 70/100,000 live births by 2030 from the current 216/100,000 is to reduce global burden of maternal mortality ratio to 70/100,000, is feasible due to collective efforts. We look forward to similarly tackling both the problems of antimicrobial resistance and cancer cure. In the editorial we focus on the success of Contemporary approach to Cancer Care for individual patients indicating the use and efficacy US FDA approved and globally implemented targeted treatment. Cancer is still an enigma both to the patients and to a considerable extent to the oncologists, due to its biological complexity and extreme heterogeneity in treatment responses in patients. The bane of cancer is metastasis of the cancer cells to distant organs introducing uncertainties in cancer cure.